Overview of coagulation factors and platelet counts in patients with type 2 diabetes mellitus: a cross-sectional study

Authors

  • Maura Salsabila Alfitri Program Studi S1 Kedokteran, Fakultas Kedokteran Universitas Andalas
  • Eva Decroli Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Andalas/ RSUP Dr. M. Djamil
  • Zelly Dia Rofinda Departemen Patologi Klinik dan Kedokteran Laboratorium, Fakultas Kedokteran Universitas Andalas/ RSUP Dr. M. Djamil
  • Dinda Aprilia Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Andalas/ RSUP Dr. M. Djamil
  • Dwi Yulia Departemen Patologi Klinik dan Kedokteran Laboratorium, Fakultas Kedokteran Universitas Andalas/ RSUP Dr. M. Djamil
  • Mutia Lailani Departemen Fisiologi, Fakultas Kedokteran Universitas Andalas

DOI:

https://doi.org/10.30989/mik.v14i2.1314

Keywords:

Blood coagulation tests, clotting factors, diabetes complications, hematologic diseases, platelet function tests, type 2 diabetes mellitus

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a growing global health threat, where chronic hyperglycemia and insulin resistance can affect coagulation profiles.
Objective: This study aims to examine coagulation factor profiles and platelet counts in T2DM patients.
Methods: A descriptive cross-sectional observational study using data from prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), and platelet counts of T2DM patients admitted to the Internal Medicine Ward of Dr. M. Djamil General Hospital, Padang, in October 2023. Data analysis was performed descriptively using SPSS v26 software.
Results: Of the 39 patients analyzed, the distribution of characteristics showed a male predominance of 64.1%, with the largest age group being 45–59 years (48.7%). The most common complication associated with T2DM was chronic kidney disease, identified in 82.1% of the study population. Evaluation of hemostasis parameters showed that APTT was prolonged in 56.4% of patients. Conversely, PT (87.2%), INR (87.2%), and platelet count (66.7%) were within reference ranges.
Conclusion: This study found most coagulation parameters normal, but a relatively high proportion had prolonged APTT, underscoring the need for individualized coagulation monitoring in T2DM, especially with renal complications

Author Biographies

Maura Salsabila Alfitri, Program Studi S1 Kedokteran, Fakultas Kedokteran Universitas Andalas

Limau Manis, Kec. Pauh, Padang 25176, Indonesia.

Eva Decroli, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Andalas/ RSUP Dr. M. Djamil

Padang, 25171, Indonesia.,

Zelly Dia Rofinda, Departemen Patologi Klinik dan Kedokteran Laboratorium, Fakultas Kedokteran Universitas Andalas/ RSUP Dr. M. Djamil

Padang, 25171, Indonesia.

Dinda Aprilia, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Andalas/ RSUP Dr. M. Djamil

Padang, 25171, Indonesia.

Dwi Yulia, Departemen Patologi Klinik dan Kedokteran Laboratorium, Fakultas Kedokteran Universitas Andalas/ RSUP Dr. M. Djamil

Padang, 25171, Indonesia.

Mutia Lailani, Departemen Fisiologi, Fakultas Kedokteran Universitas Andalas

Limau Manis, Kec. Pauh, Padang 25176, Indonesia.

References

1. World Health Organization. Diabetes. April 5, 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes

2. Badan Penelitian Dan Pengembangan Kesehatan. Hasil Utama Riskesdas 2018. Lembaga Penerbit Badan Penelitian Dan Pengembangan Kesehatan; 2018.

3. Fan W. Epidemiology In Diabetes Mellitus And Cardiovascular Disease. Cardiovasc Endocrinol. 2017;6(1):8-16.

4. Mukhyarjon, Wahid I, Manaf A. Profil Dan Beberapa Faktor Yang Berhubungan Dengan Hemostasis Pasien Diabetes Melitus Tipe 2 Tak Terkontrol. Jurnal Kedokteran Dan Kesehatan. 2020;16.

5. Suharti C. Dasar-Dasar Hemostasis. In: 2009.

6. Setiabudy Rd. Hemostasis Dan Trombosis. 6th Ed. Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2018.

7. Durachim A, Astuti D. Buku Ajar Teknologi Laboratorium Medik Hemostasis. Pertama.; 2018.

8. Ardina R, Sartika F, Nainggolan Lp. APTT (Activated Partial Thromboplastin Time) and PT (Prothrombin Time) Pada Penderita Diabetes Melitus Tipe 2 di RSUD Dr. Doris Sylvanus Palangkaraya. Borneo Journal of Medical Laboratory Technology APTT. 2020;2(2).

9. Herawati F, Umar F, Pahlemy H, et al. Pedoman Interpretasi Data Klinik.; 2011.

10. Pramudita N, Mulyantari NK. Gambaran Hasil Pemeriksaan Faal Hemostasis Pada Penderita Diabetes Melitus Tipe-2 (DM-2) Di RSUP Sanglah, Bali, Indonesia. Intisari Sains Medis. 2019;10(2).

11. Nordström A, Hadrévi J, Olsson T, Franks PW, Nordström P. Higher Prevalence of Type 2 Diabetes in Men than in Women is Associated with Differences in Visceral Fat Mass. Journal of Clinical Endocrinology and Metabolism. 2016;101(10):3740-3746.

12. Aryndra R, Kabosu S, Adu Aa, Et Al. Faktor Risiko Kejadian Diabetes Melitus Tipe Dua di RS Bhayangkara Kota Kupang. Vol 1.; 2019.

13. Nowakowska M, Zghebi SS, Ashcroft DM, et al. The Comorbidity Burden of Type 2 Diabetes Mellitus: Patterns, Clusters and Predictions from a Large English Primary Care Cohort. BMC Med. 2019;17(1):145.

14. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining Comorbidity: Implications for Understanding Health and Health Services. The Annals of Family Medicine. 2009;7(4):357-363.

15. Thukral S, Hussain S, Bhat S, Kaur N, Reddy A. Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) in Type 2 Diabetes Mellitus, a Case Control Study. International Journal of Contemporary Medical Research [IJCMR]. 2018;5(8).

16. Ebrahim H, Asrie F, Getaneh Z. Basic Coagulation Profiles and Platelet Parameters among Adult Type 1 and Type 2 Diabetes Patients at Dessie Referral Hospital, Northeast Ethiopia: Comparative Cross-Sectional Study. J Blood Med. 2021; Volume 12:33-42.

17. Li X, Weber NC, Cohn DM, et al. Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis. J Clin Med. 2021;10(11).

18. Perdamaian G, Tobing Ml. Gambaran Koagulasi pada Darah Pasien Diabetes Melitus yang Menjalani Hemodialisis (di RSUP Dr.Kariadi Semarang). Vol 4.; 2015.

19. Ephraim RKD, Awuku YA, Adu P, et al. High Risk of Coagulopathy among Type-2 Diabetes Mellitus Clients at a Municipal Hospital in Ghana. Ghana Med J. 2017;51(3):101.

20. B A, Sodhi HS, Modala S, Baghel M. A Comparative Study of Coagulation Time in Type 2 Diabetes Mellitus and Healthy Individuals. Vol 3.; 2016.

21. Hasanah AD. Gambaran Jumlah Trombosit Pada Penderita Diabetes Melitus Tipe 2 di RSU Bunda Palembang Tahun 2019. Published Online 2019.

22. Raja V, Ganapathy S, Karthikean SK, Das Prakash P. Impact of Haemodialysis on Coagulation Profile in Chronic Kidney Disease. Annals of Pathology and Laboratory Medicine. 2021;8(3):A95-99.

23. Budiman A, Yuliandari A, Sembiring RS. Gambaran Jumlah Trombosit Pada Pasien Diabetes Melitus Tipe 2. Zahra: Journal of Health and Medical Research. 2022;2(4):276-283.

Downloads

Published

2025-08-30

How to Cite

1.
Alfitri MS, Decroli E, Rofinda ZD, Aprilia D, Yulia D, Lailani M. Overview of coagulation factors and platelet counts in patients with type 2 diabetes mellitus: a cross-sectional study. Media ilmu kesehatan [Internet]. 2025 Aug. 30 [cited 2025 Aug. 31];14(2):199-208. Available from: https://ejournal.unjaya.ac.id/index.php/mik/article/view/1314